SCMP
RhumbLine Advisers’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-57,747
| Closed | -$1.04M | – | 2844 |
|
|
2017
Q4 | $1.04M | Buy |
57,747
+7,397
| +15% | +$133K | ﹤0.01% | 1929 |
|
|
2017
Q3 | $594K | Buy |
50,350
+1,540
| +3% | +$18.2K | ﹤0.01% | 2227 |
|
|
2017
Q2 | $513K | Buy |
48,810
+423
| +0.9% | +$4.45K | ﹤0.01% | 2280 |
|
|
2017
Q1 | $532K | Buy |
48,387
+19,737
| +69% | +$217K | ﹤0.01% | 2216 |
|
|
2016
Q4 | $388K | Buy |
28,650
+1,295
| +5% | +$17.5K | ﹤0.01% | 2357 |
|
|
2016
Q3 | $337K | Buy |
27,355
+425
| +2% | +$5.24K | ﹤0.01% | 2418 |
|
|
2016
Q2 | $295K | Buy |
26,930
+580
| +2% | +$6.35K | ﹤0.01% | 2547 |
|
|
2016
Q1 | $288K | Buy |
26,350
+170
| +0.6% | +$1.86K | ﹤0.01% | 2548 |
|
|
2015
Q4 | $453K | Buy |
26,180
+3,175
| +14% | +$54.9K | ﹤0.01% | 2305 |
|
|
2015
Q3 | $457K | Buy |
23,005
+922
| +4% | +$18.3K | ﹤0.01% | 2287 |
|
|
2015
Q2 | $363K | Buy |
22,083
+4,570
| +26% | +$75.1K | ﹤0.01% | 2528 |
|
|
2015
Q1 | $273K | Buy |
17,513
+2,780
| +19% | +$43.3K | ﹤0.01% | 2666 |
|
|
2014
Q4 | $210K | Buy |
14,733
+325
| +2% | +$4.63K | ﹤0.01% | 2792 |
|
|
2014
Q3 | $94K | Hold |
14,408
| – | – | ﹤0.01% | 2934 |
|
|
2014
Q2 | $99K | Buy |
14,408
+1,527
| +12% | +$10.5K | ﹤0.01% | 2971 |
|
|
2014
Q1 | $92K | Sell |
12,881
-660
| -5% | -$4.71K | ﹤0.01% | 2931 |
|
|
2013
Q4 | $127K | Hold |
13,541
| – | – | ﹤0.01% | 2938 |
|
|
2013
Q3 | $84K | Sell |
13,541
-144
| -1% | -$893 | ﹤0.01% | 2947 |
|
|
2013
Q2 | $90K | Buy |
+13,685
| New | +$90K | ﹤0.01% | 3258 |
|